SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-029889
Filing Date
2022-11-14
Accepted
2022-11-14 16:46:17
Documents
72
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q prme-20220930.htm   iXBRL 10-Q 2184666
2 EX-31.1 ex311.htm EX-31.1 11597
3 EX-31.2 ex312.htm EX-31.2 11650
4 EX-32.1 ex321.htm EX-32.1 7487
5 EX-32.2 ex322.htm EX-32.2 7549
  Complete submission text file 0001628280-22-029889.txt   8081636

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prme-20220930.xsd EX-101.SCH 49969
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prme-20220930_cal.xml EX-101.CAL 63122
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prme-20220930_def.xml EX-101.DEF 288662
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prme-20220930_lab.xml EX-101.LAB 605694
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prme-20220930_pre.xml EX-101.PRE 414577
66 EXTRACTED XBRL INSTANCE DOCUMENT prme-20220930_htm.xml XML 1195529
Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41536 | Film No.: 221386881
SIC: 2836 Biological Products, (No Diagnostic Substances)